ArticleFrontiers in oncology2024

Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation.

Jie Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.